Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Concin

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Cancers|June 2, 2021
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD ConsortiumEva Obermayr, Angelika Reiner, Burkhard Brandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancerLukas A Hefler, Alexander Mustea, Dominique Könsgen, et al.
Oncotargets and Therapy|September 24, 2014
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumElena Ioana Braicu, Hrvoje Luketina, Rolf Richter, et al.
The Oncologist|September 25, 2009
Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter studyStephan Polterauer, Christoph Grimm, Veronika Seebacher, et al.
Cancer Research|May 13, 2010
E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancerDaniel Reimer, Michael Hubalek, Svenja Riedle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancerLukas A Hefler, Nicole Concin, Gerda Hofstetter, et al.
Cancers|December 10, 2021
Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD ConsortiumEva Obermayr, Elena Ioana Braicu, Stephan Polterauer, et al.
Gynecologic Oncology|October 15, 2023
Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal studyMajdi Imterat, Gudrun Gebers, Florian Heitz, et al.
Gynecologic Oncology|March 28, 2012
External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancerStephan Polterauer, Qin Zhou, Christoph Grimm, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 24, 2012
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD dataStephan Polterauer, Ignace Vergote, Nicole Concin, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Cancers|June 2, 2021
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD ConsortiumEva Obermayr, Angelika Reiner, Burkhard Brandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancerLukas A Hefler, Alexander Mustea, Dominique Könsgen, et al.
Oncotargets and Therapy|September 24, 2014
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumElena Ioana Braicu, Hrvoje Luketina, Rolf Richter, et al.
The Oncologist|September 25, 2009
Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter studyStephan Polterauer, Christoph Grimm, Veronika Seebacher, et al.
Cancer Research|May 13, 2010
E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancerDaniel Reimer, Michael Hubalek, Svenja Riedle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancerLukas A Hefler, Nicole Concin, Gerda Hofstetter, et al.
Cancers|December 10, 2021
Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD ConsortiumEva Obermayr, Elena Ioana Braicu, Stephan Polterauer, et al.
Gynecologic Oncology|October 15, 2023
Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal studyMajdi Imterat, Gudrun Gebers, Florian Heitz, et al.
Gynecologic Oncology|March 28, 2012
External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancerStephan Polterauer, Qin Zhou, Christoph Grimm, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 24, 2012
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD dataStephan Polterauer, Ignace Vergote, Nicole Concin, et al.
Pageof 14